UPDATE: Piper Sandler Starts Affimed Therapeutics (AFMD) at Overweight
Tweet Send to a Friend
(Updated - March 30, 2022 4:13 PM EDT)
Piper Sandler analyst Do Kim initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Do Kim initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
